News Releases 2024

【Mitsubishi Tanabe Pharma】“Zepbound^®”, a Long-Acting GIP/GLP-1 Receptor Agonist, Approved for the Chronic Disease of “Obesity Disease” with Multiple Factors

Mitsubishi Chemical Group Selected for Dow Jones Sustainability World Index for Eight Consecutive Years

Kagawa Plant to increase production capacity of anode material for automotive lithium-ion batteries

Expansion of Production Capacity of Synthetic Silica Powder for Semiconductors at the Kyushu Plant

Bio-based Engineering Plastic DURABIO Adopted by Honda for its Motorcycle Bodywork and Windshields-Toughness and paintless design capability opening up mobility applications-

Mitsubishi Chemical Group, Deloitte Tohmatsu, and Classiq Compress Quantum Circuits by Up to 97%

Bio-based Engineering Plastic DURABIO used on front grille of Suzuki's new Fronx compact SUV

【Mitsubishi Tanabe Pharma】Mitsubishi Tanabe Pharma Corporation Entered into Research Collaboration with Dewpoint to Advance Small Molecule Condensate Modulator for ALS

Notice regarding formulation of “KAITEKI Vision 35” and “New Medium-Term Management Plan 2029”

Enhancement of Our Semiconductor Precision Cleaning Business in Japan: Shinryo Corporation to Establish a New Plant in Fukushima and Expand the Iwate Plant

Diamond Edge Ventures Announces Strategic Investment in Boston Materials to Support Next-Generation Semiconductor and Aerospace Solutions

Consolidated Financial Results for the First Half of the Fiscal Year Ending March 31, 2025 (Under IFRS)

【Mitsubishi Tanabe Pharma】Update on U.S. Development Plan of Investigational ND0612 for the Treatment of Motor Fluctuations in People with Parkinson’s Disease

Conducting Demonstration Tests of a Traceability System for Chemical Recycling in Collaboration with Chaintope Inc. to Build Transparent and Reliable Supply Chains

BioPTMG, a Plant-Derived Polyurethane Raw Material, Now Used in Bio-Synthetic Leather Bags and Other Products

Launch of Higher Biomass Content Grades of Biomass-based Polycarbonatediol “BENEBiOL”-Contributing to sustainable manufacturing while maintaining high-quality functions-

Mitsubishi Chemical Group Expands Production Facility for Optical Film for Polarizing Plates, OPL Film

Mitsubishi Chemical Group Expands Production Capacity for Ion Exchange Resins Used in the Production of Ultrapure Water for Semiconductors

Results of a Joint Research Project with the University of Tokyo on Safeguarding the Global Commons -New Report Outlines Pathways and Strategies to Achieve Net Zero for the Japanese Chemical Industry-

International Sustainability and Carbon Certification “ISCC PLUS Certification” Newly Acquired

Promotion of a communication and interoperation standard connecting instruments for next-generation laboratories

International Sustainability and Carbon Certification “ISCC PLUS Certification” Newly Acquired

Transfer of Triacetate Fiber Business

Performance Polymers Products Site in Japan Acquires ISCC PLUS Certification

The Effects of a Spore-forming Lactic acid producing bacteria Probiotic on Improvement of Intestinal Environment and Skin Condition Have Been Demonstrated

【Mitsubishi Tanabe Pharma】Termination of Exclusive Sales Rights Agreements for HGF Gene Therapy Product "Collategene_®" in Japan and the US

Launch Studies on Chemical Recycling of End-of-Life Tires Utilizing Coke Ovens - Commercialize Sustainable Carbon Black by March 2026 -

Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2025 (Under IFRS)

【Mitsubishi Tanabe Pharma】Notice Regarding Implementation of Voluntary Retirement Program

【Mitsubishi Tanabe Pharma】Moderna And Mitsubishi Tanabe Pharma Corporation Enter Joint Agreement to Promote Moderna's mRNA Respiratory Vaccine Portfolio in Japan, Including COVID-19 Vaccines

The Improvement Effects of a Spore-forming Lactic acid producing bacteria Probiotic on Cold-like Symptoms Have Been Demonstrated

【Mitsubishi Tanabe Pharma】Distribution Discontinuation of HGF gene therapy product "Collategene_®", following withdrawal of the manufacturing and marketing approval application

“XANTAR K Series” High-performance Polycarbonate Resin Adopted in the Nothing Phone (2a), a Smartphone from the U.K.

【Mitsubishi Tanabe Pharma】Transfer of Argatroban Business in Europe

Mitsubishi Chemical Group expands production of its Lithomax photosensitive polymers for semiconductor photoresists – New facility at Kyushu-Fukuoka Plant to produce Lithomax for ArF and EUV photoresists –

【Mitsubishi Tanabe Pharma】Receipt of Complete Response Letter from U.S. FDA for ND0612

【Mitsubishi Tanabe Pharma】Alesion® Eyelid Cream 0.5%, a new treatment for allergic conjunctivitis, goes on sale in Japan- World-first cream-type allergic conjunctivitis treatment requiring just once daily administration to the upper and lower eyelids -

【Mitsubishi Tanabe Pharma】Announcement of launch of SGLT2 inhibitor "CANAGLU OD Tablets" ～Adoption of Environmentally Friendly Biomass-plastic PTP Sheets～

Biomass-based Polycarbonatediol BENEBiOL to Be Used in AEROX's Coatings for Wind Turbine Blade Leading Edge Protection

DURABIO, the World’s First Bio-based Engineering Plastic, Adopted by Honda for its Motorcycle Windshields

Consolidated Financial Results for the Fiscal Year Ended March 31, 2024 (Under IFRS)

【Mitsubishi Tanabe Pharma】The Global Health Innovative Technology Fund provides grant to Mitsubishi Tanabe Pharma and DNDi for Chagas disease drug discovery

Lawson Selects BENEBiOL, a Biomass-based Polycarbonatediol, for New Store in Aomori Prefecture, Japan

【Mitsubishi Tanabe Pharma】Announcement of Approval Submission and Marketing Alliance in Japan for Tirzepatide as a Drug for Obesity Disease

【Mitsubishi Tanabe Pharma】Santen and Mitsubishi Tanabe Pharma announce the conclusion of a contract for the joint sales promotion in Japan of Alesion^® Eyelid Cream 0.5%, a new treatment for allergic conjunctivitis

Seedling pots using “Forzeas,” a plant-derived biodegradable resin compound, which allow seedlings to be planted without removing the pots sold at LAKE HAMANA HANAHAKU 2024
Specially designed five-color set with the mark of HANAHAKU 2024 engraved available

Components with Compliant Mechanism Design Adopted for Lunar Rover YAOKI

【Mitsubishi Tanabe Pharma】RADICAVA ORS^® as Orphan drug designation and approval in US

Biomass-based Polycarbonatediol “BENEBiOL” Adopted for the Watch Band of Citizen Watch

Main building of Mitsubishi Chemical Group's Science & Innovation Center receives WELL Building Standard v2 pilot certification

【Mitsubishi Tanabe Pharma】Announcement of Publication in The Lancet Neurology from the Clinical Study of Investigational ND0612 for Parkinson's Disease

【Mitsubishi Tanabe Pharma】Additional Approval of SGLT2 inhibitor CANAGLU® OD Tablets～First OD Tablets of SGLT2 inhibitors in Japan～

Nichigo G-Polymer, a special brand of polyvinyl alcohol, certified as a recyclable material for polyethylene-based multilayer packaging materials in Europe

【Mitsubishi Tanabe Pharma】Launch of "GOBIK Aqueous Suspension Syringes", Pertussis, Diphtheria, Tetanus, Inactivated Polio and Hib Combined Vaccine

Mitsubishi Chemical Group announces the Winner of the 3D Printing FGF Engineering Challenge

Mitsubishi Chemical Group Develops BiOpreg #400 Series Carbon Fiber Prepreg Using Plant-Derived Resin

【Mitsubishi Tanabe Pharma】Expiration of Marketing Alliance Agreement for TENELIA® Tablets, TENELIA® OD Tablets and CANAGLU® Tablets

Mitsubishi Chemical Group to increase Sugar Ester emulsifier production capacity
Will add new line to Kyushu Plant to meet global demand for high-quality food products

【Mitsubishi Tanabe Pharma】Launch of Radicava® for the Treatment of ALS in Brazil～First successful launch by a partner in global expansion～

Announcement on the Discontinuance of MMA Production by the ACH Process and Acrylonitrile-Related Production at the Hiroshima Plant, and on Subsequent Withdrawal from Some Businesses

【Mitsubishi Tanabe Pharma】Application for Additional Dosage Form of CANALIA® Combination OD Tablets, Selective DPP-4 inhibitor/SGLT2 inhibitor Combination Drug

Plant-derived bioengineering plastic DURABIO used in Sunstar’s Ora² Toothbrush

Mitsubishi Chemical Group Develops Carbon Fiber-based 1,500 ﾂｰC Heat-Resistant Ceramic Matrix Composite (C/SiC)

Signed a Comprehensive Collaboration Agreement with Fukui Prefecture to Build a Sustainable Society

Newly Developed Biodegradable Biopolyester Resins
- High biomass content, flexibility, high tear strength, and excellent processability -

Developed “NOVADURAN ZR Series” Foaming Polybutylene Terephthalate Resin
- Enables the production of molded products with ultra-low specific gravity less than 1.0 in a simple process -

Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2024 (Under IFRS)

【Mitsubishi Tanabe Pharma】Transfer of Three Marketed Products in Japan

【Mitsubishi Tanabe Pharma】Mitsubishi Tanabe Pharma contribute funding to Global Health Innovative Technology Fund's third phase ―Targeting treatments for infectious diseases that burden the developing world―

Mitsubishi Chemical Group to Commence Full-fledged Verification Testing for the World’s First Commercialization of Polycarbonate Resin Chemical Recycling
Conducting testing for collecting polycarbonate resin from headlamps of end-of-life vehicles in collaboration with Tokio Marine & Nichido and ABT

Plant-derived Bioengineering Plastic DURABIO Selected by Panasonic for Wireless Earphones

【Mitsubishi Tanabe Pharma】Co-promotion of "GOBIK Aqueous Suspension Syringes", Pertussis, Diphtheria, Tetanus, Inactivated Polio and Hib Combined Vaccine

New Year Message from President and CEO, Jean-Marc Gilson (summary)